Biofunctional quantum dots as fluorescence probe for cell-specific targeting

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Didem Ag
  • Rebecca Bongartz
  • Leyla Eral Dogan
  • Muharrem Seleci
  • Johanna G. Walter
  • Dilek Odaci Demirkol
  • Frank Stahl
  • Serdar Ozcelik
  • Suna Timur
  • Thomas Scheper

Research Organisations

External Research Organisations

  • Ege University
  • İzmir Institute of Technology
View graph of relations

Details

Original languageEnglish
Pages (from-to)96-103
Number of pages8
JournalColloids and Surfaces B: Biointerfaces
Volume114
Publication statusPublished - 4 Oct 2013

Abstract

We describe here the synthesis, characterization, bioconjugation, and application of water-soluble thioglycolic acid TGA-capped CdTe/CdS quantum dots (TGA-QDs) for targeted cellular imaging. Anti-human epidermal growth factor receptor 2 (HER2) antibodies were conjugated to TGA-QDs to target HER2-overexpressing cancer cells. TGA-QDs and TGA-QDs/anti-HER2 bioconjugates were characterized by fluorescence and UV-Vis spectroscopy, X-ray diffraction (XRD), hydrodynamic sizing, electron microscopy, and gel electrophoresis. TGA-QDs and TGA-QDs/anti-HER2 were incubated with cells to examine cytotoxicity, targeting efficiency, and cellular localization. The cytotoxicity of particles was measured using an MTT assay and the no observable adverse effect concentration (NOAEC), 50% inhibitory concentration (IC50), and total lethal concentration (TLC) were calculated. To evaluate localization and targeting efficiency of TGA-QDs with or without antibodies, fluorescence microscopy and flow cytometry were performed. Our results indicate that antibody-conjugated TGA-QDs are well-suited for targeted cellular imaging studies.

Keywords

    Anti-HER2, Bioconjugation, Cell specific targeting, Imaging, Quantum dots

ASJC Scopus subject areas

Sustainable Development Goals

Cite this

Biofunctional quantum dots as fluorescence probe for cell-specific targeting. / Ag, Didem; Bongartz, Rebecca; Dogan, Leyla Eral et al.
In: Colloids and Surfaces B: Biointerfaces, Vol. 114, 04.10.2013, p. 96-103.

Research output: Contribution to journalArticleResearchpeer review

Ag, D, Bongartz, R, Dogan, LE, Seleci, M, Walter, JG, Demirkol, DO, Stahl, F, Ozcelik, S, Timur, S & Scheper, T 2013, 'Biofunctional quantum dots as fluorescence probe for cell-specific targeting', Colloids and Surfaces B: Biointerfaces, vol. 114, pp. 96-103. https://doi.org/10.1016/j.colsurfb.2013.09.033
Ag, D., Bongartz, R., Dogan, L. E., Seleci, M., Walter, J. G., Demirkol, D. O., Stahl, F., Ozcelik, S., Timur, S., & Scheper, T. (2013). Biofunctional quantum dots as fluorescence probe for cell-specific targeting. Colloids and Surfaces B: Biointerfaces, 114, 96-103. https://doi.org/10.1016/j.colsurfb.2013.09.033
Ag D, Bongartz R, Dogan LE, Seleci M, Walter JG, Demirkol DO et al. Biofunctional quantum dots as fluorescence probe for cell-specific targeting. Colloids and Surfaces B: Biointerfaces. 2013 Oct 4;114:96-103. doi: 10.1016/j.colsurfb.2013.09.033
Ag, Didem ; Bongartz, Rebecca ; Dogan, Leyla Eral et al. / Biofunctional quantum dots as fluorescence probe for cell-specific targeting. In: Colloids and Surfaces B: Biointerfaces. 2013 ; Vol. 114. pp. 96-103.
Download
@article{98bb99d826884672930f380e80d95739,
title = "Biofunctional quantum dots as fluorescence probe for cell-specific targeting",
abstract = "We describe here the synthesis, characterization, bioconjugation, and application of water-soluble thioglycolic acid TGA-capped CdTe/CdS quantum dots (TGA-QDs) for targeted cellular imaging. Anti-human epidermal growth factor receptor 2 (HER2) antibodies were conjugated to TGA-QDs to target HER2-overexpressing cancer cells. TGA-QDs and TGA-QDs/anti-HER2 bioconjugates were characterized by fluorescence and UV-Vis spectroscopy, X-ray diffraction (XRD), hydrodynamic sizing, electron microscopy, and gel electrophoresis. TGA-QDs and TGA-QDs/anti-HER2 were incubated with cells to examine cytotoxicity, targeting efficiency, and cellular localization. The cytotoxicity of particles was measured using an MTT assay and the no observable adverse effect concentration (NOAEC), 50% inhibitory concentration (IC50), and total lethal concentration (TLC) were calculated. To evaluate localization and targeting efficiency of TGA-QDs with or without antibodies, fluorescence microscopy and flow cytometry were performed. Our results indicate that antibody-conjugated TGA-QDs are well-suited for targeted cellular imaging studies.",
keywords = "Anti-HER2, Bioconjugation, Cell specific targeting, Imaging, Quantum dots",
author = "Didem Ag and Rebecca Bongartz and Dogan, {Leyla Eral} and Muharrem Seleci and Walter, {Johanna G.} and Demirkol, {Dilek Odaci} and Frank Stahl and Serdar Ozcelik and Suna Timur and Thomas Scheper",
note = "Funding information: This work is supported by Scientific and Technological Research Council of Turkey (TUBITAK, project number 109T573 ) and Federal Ministry of Education and Research (BMBF, project number 01DL12013 ). Also it was partially funded by Ege University Scientific Research Project ( 2012/FEN/0071 ). We are grateful to Michael Meyer (Gottfried Wilhelm Leibniz University of Hannover, Institute for Technical Chemistry) for his knowledge and time spent carrying out flow cytometry experiments. In addition our thanks go to F. B. Barlas (Ege University, Faculty of Science, Biochemistry department) for taking fluorescence microscope images.",
year = "2013",
month = oct,
day = "4",
doi = "10.1016/j.colsurfb.2013.09.033",
language = "English",
volume = "114",
pages = "96--103",
journal = "Colloids and Surfaces B: Biointerfaces",
issn = "0927-7765",
publisher = "Elsevier",

}

Download

TY - JOUR

T1 - Biofunctional quantum dots as fluorescence probe for cell-specific targeting

AU - Ag, Didem

AU - Bongartz, Rebecca

AU - Dogan, Leyla Eral

AU - Seleci, Muharrem

AU - Walter, Johanna G.

AU - Demirkol, Dilek Odaci

AU - Stahl, Frank

AU - Ozcelik, Serdar

AU - Timur, Suna

AU - Scheper, Thomas

N1 - Funding information: This work is supported by Scientific and Technological Research Council of Turkey (TUBITAK, project number 109T573 ) and Federal Ministry of Education and Research (BMBF, project number 01DL12013 ). Also it was partially funded by Ege University Scientific Research Project ( 2012/FEN/0071 ). We are grateful to Michael Meyer (Gottfried Wilhelm Leibniz University of Hannover, Institute for Technical Chemistry) for his knowledge and time spent carrying out flow cytometry experiments. In addition our thanks go to F. B. Barlas (Ege University, Faculty of Science, Biochemistry department) for taking fluorescence microscope images.

PY - 2013/10/4

Y1 - 2013/10/4

N2 - We describe here the synthesis, characterization, bioconjugation, and application of water-soluble thioglycolic acid TGA-capped CdTe/CdS quantum dots (TGA-QDs) for targeted cellular imaging. Anti-human epidermal growth factor receptor 2 (HER2) antibodies were conjugated to TGA-QDs to target HER2-overexpressing cancer cells. TGA-QDs and TGA-QDs/anti-HER2 bioconjugates were characterized by fluorescence and UV-Vis spectroscopy, X-ray diffraction (XRD), hydrodynamic sizing, electron microscopy, and gel electrophoresis. TGA-QDs and TGA-QDs/anti-HER2 were incubated with cells to examine cytotoxicity, targeting efficiency, and cellular localization. The cytotoxicity of particles was measured using an MTT assay and the no observable adverse effect concentration (NOAEC), 50% inhibitory concentration (IC50), and total lethal concentration (TLC) were calculated. To evaluate localization and targeting efficiency of TGA-QDs with or without antibodies, fluorescence microscopy and flow cytometry were performed. Our results indicate that antibody-conjugated TGA-QDs are well-suited for targeted cellular imaging studies.

AB - We describe here the synthesis, characterization, bioconjugation, and application of water-soluble thioglycolic acid TGA-capped CdTe/CdS quantum dots (TGA-QDs) for targeted cellular imaging. Anti-human epidermal growth factor receptor 2 (HER2) antibodies were conjugated to TGA-QDs to target HER2-overexpressing cancer cells. TGA-QDs and TGA-QDs/anti-HER2 bioconjugates were characterized by fluorescence and UV-Vis spectroscopy, X-ray diffraction (XRD), hydrodynamic sizing, electron microscopy, and gel electrophoresis. TGA-QDs and TGA-QDs/anti-HER2 were incubated with cells to examine cytotoxicity, targeting efficiency, and cellular localization. The cytotoxicity of particles was measured using an MTT assay and the no observable adverse effect concentration (NOAEC), 50% inhibitory concentration (IC50), and total lethal concentration (TLC) were calculated. To evaluate localization and targeting efficiency of TGA-QDs with or without antibodies, fluorescence microscopy and flow cytometry were performed. Our results indicate that antibody-conjugated TGA-QDs are well-suited for targeted cellular imaging studies.

KW - Anti-HER2

KW - Bioconjugation

KW - Cell specific targeting

KW - Imaging

KW - Quantum dots

UR - http://www.scopus.com/inward/record.url?scp=84886626978&partnerID=8YFLogxK

U2 - 10.1016/j.colsurfb.2013.09.033

DO - 10.1016/j.colsurfb.2013.09.033

M3 - Article

C2 - 24176888

AN - SCOPUS:84886626978

VL - 114

SP - 96

EP - 103

JO - Colloids and Surfaces B: Biointerfaces

JF - Colloids and Surfaces B: Biointerfaces

SN - 0927-7765

ER -

By the same author(s)